Advance Technology
Healthcare Solutions
In 2020, Abdul Latif Jameel Enterprises has also set up an innovative healthcare solutions business, thus expanding into a new sector to introduce new medical devices, health-tech solutions, and healthcare services to Saudi Arabia.
Part of the global Abdul Latif Jameel Health division the expansion into this sector follows the successful introduction of cutting-edge Japanese robotic exoskeleton technology to rehabilitate patients with neuromuscular diseases such as spinal injuries at the Abdul Latif Jameel Rehabilitation Hospital in Jeddah since 2018, in collaboration with Japanese company Cyberdyne Inc.
Treating Spinal Injuries with Cyberdyne Medical HAL® [Hybrid Assistive Limb®] Technology
Cyberdyne’s medical HAL® [Hybrid Assistive Limb®] is a form of robotic exoskeleton technology that can regenerate, improve, support, and expand patients’ brain-neuro-physical functions. It is designed for use in therapies to treat patients with disorders and/or weakening in the lower limbs due to neuromuscular diseases such as spinal cord injuries, brain trauma, and strokes.
Cyberdyne’s medical HAL® [Hybrid Assistive Limb®] is a form of robotic exoskeleton technology that can regenerate, improve, support, and expand patients’ brain-neuro-physical functions. It is designed for use in therapies to treat patients with disorders and/or weakening in the lower limbs due to neuromuscular diseases such as spinal cord injuries, brain trauma, and strokes.
In January 2019, the partnership between Abdul Latif Jameel Enterprises, Cyberdyne, and the Ministry of Health was enhanced. As a result, 8 patients from King Fahad Medical City (Riyadh) and King Abdulaziz Hospital (Jeddah) received rehabilitation by HAL® robots under the care of certified physiotherapists from the Ministry of Health. This enhanced partnership has appointed Abdul Latif Jameel Enterprises as the distributor of the technology in the Kingdom of Saudi Arabia and Abdul Latif Jameel Hospital as the regional training center.
Success Stories:
Abdul Rehman En
English Abdul Rehman Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Al Hakami 1
Al Hakami Al Hakami Al Hakami Al Hakami 2
Approvals - Publications:
- The device obtained CE Marking [CE 0197] for the first time as a robotic medical device in the EU.
- The device obtained the American FDA approval in 2017
- The device obtained its Saudi SFDA approval in 2017
- Cyberdyne Inc. Received ISO13485 (Medical Device) for the first-ever robotic medical device manufacturer
- Neurosurgical Focus published a medical study in 2017 on the rehabilitation of chronic spinal cord injury with HAL® exoskeleton on a subgroup of 55 patients
- Article published in Neurology® the official magazine of the American Academy of Neurology in 2014.
Global Presence and partnerships
English Global
English Global desc
Global 2 Eng
Global 2 Eng Desc
English Global
English Global desc
Global 2 Eng
Global 2 Eng Desc